Skip to main content

Table 1 Comparison of intervention and standard of care arms for potentially important confounding variables at baseline

From: An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

Variable

Intervention (n = 27)

Standard (n = 25)

Demographic

 Male (%)

13 (48.2%)

13 (52%)

 Age: Mean (range)

38.2 (23–56)

32.5 (17–58)

 UK Born

2 (7.4%)

3 (12%)

Lifestyle

 Concomitant medication

9 (33.3%)

5 (20%)

 Alcohol - current

9 (33.3%)

9 (36%)

Smoking

 Current

3 (11.1%)

6 (24.0%)

 Ex

2 (7.4%)

3 (12.0%)

 Never

22 (88.5%)

16 (64.0%)

Clinical

 IGRA positive

24 (88.9%)

24 (96%)

 TST positive

3 (11.1%)

1 (4%)

 Diabetes

1 (3.7%)

1 (4%)

 Immunosuppressant medication

1 (3.7%)